Treatment with a tumor necrosis factor inhibitor is not associated with greater risk for lymphoma, according to a large study presented at the American College of Rheumatology's 2012 meeting. However, researchers led by the University of Manchester's Louise K. Mercer said "further follow-up is needed to establish if the picture changes with time."

Related Summaries